UM  > 中華醫藥研究院
Global patent landscape of programmed cell death 1: implications of the rapid expansion
Kong, Xiangjun1; Zhang, Qianru1,2; Lai, Yunfeng1; Hu, Hao1; Chen, Xin1; Hu, Yuanjia1
2018
Source PublicationEXPERT OPINION ON THERAPEUTIC PATENTS
ISSN1354-3776
Volume28Issue:1Pages:69-80
Abstract

Introduction: Inhibitors of programmed cell death 1 (PD-1) and its ligands are producing a paradigm shift in cancer treatment. The promising clinical outcomes and a multi-billion dollar market have prompted active research and development and resulted in relentless patent protection. However, the global patent landscape in this field remains unclear.

KeywordProgrammed Cell Death 1 (Pd-1) Patent Landscape Patent Citation Network Co-patent Technology Flow Immunotherapy
DOI10.1080/13543776.2017.1378349
URLView the original
Indexed BySCI ; SSCI ; SSCI
Language英语
WOS Research AreaPharmacology & Pharmacy
WOS SubjectChemistry, Medicinal ; Pharmacology & Pharmacy
WOS IDWOS:000427054100006
PublisherTAYLOR & FRANCIS LTD
The Source to ArticleWOS
Fulltext Access
Citation statistics
Cited Times [WOS]:2   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Affiliation1.Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine , University of Macau , Macao , China
2.Pharmacy School , Zunyi Medical University , Macao , China.
First Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Kong, Xiangjun,Zhang, Qianru,Lai, Yunfeng,et al. Global patent landscape of programmed cell death 1: implications of the rapid expansion[J]. EXPERT OPINION ON THERAPEUTIC PATENTS,2018,28(1):69-80.
APA Kong, Xiangjun,Zhang, Qianru,Lai, Yunfeng,Hu, Hao,Chen, Xin,&Hu, Yuanjia.(2018).Global patent landscape of programmed cell death 1: implications of the rapid expansion.EXPERT OPINION ON THERAPEUTIC PATENTS,28(1),69-80.
MLA Kong, Xiangjun,et al."Global patent landscape of programmed cell death 1: implications of the rapid expansion".EXPERT OPINION ON THERAPEUTIC PATENTS 28.1(2018):69-80.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Kong, Xiangjun]'s Articles
[Zhang, Qianru]'s Articles
[Lai, Yunfeng]'s Articles
Baidu academic
Similar articles in Baidu academic
[Kong, Xiangjun]'s Articles
[Zhang, Qianru]'s Articles
[Lai, Yunfeng]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Kong, Xiangjun]'s Articles
[Zhang, Qianru]'s Articles
[Lai, Yunfeng]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.